OCTREOTIDE FOR MEDULLARY-THYROID CARCINOMA ASSOCIATED DIARRHEA

被引：0
|
作者：
SMID, WM [1 ]
DULLAART, RPF [1 ]
机构：
[1] UNIV GRONINGEN HOSP,DEPT ENDOCRINOL,9713 EZ GRONINGEN,NETHERLANDS
来源：
NETHERLANDS JOURNAL OF MEDICINE | 1992年 / 40卷 / 5-6期
关键词：
MEDULLARY THYROID CARCINOMA; DIARRHEA; OCTREOTIDE; CALCITONIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Medullary thyroid carcinoma associated diarrhoea can be disabling. A 75-yr-old man with metastatic medullary thyroid carcinoma and refractory diarrhoea is described. Subcutaneous administration of the somatostatin analogue, octreotide, 100-mu-g thrice daily, resulted in a sustained improvement in diarrhoea and disappearance of faecal incontinence without reducing calcitonin levels. Octreotide therapy should be considered as symptomatic treatment for otherwise refractory diarrhoea associated with medullary thyroid carcinoma.
引用
收藏
页码：240 / 243
页数：4
相关论文
共 50 条
12345